Erlotinib

Author： Robinson Dean M.   Keating Gillian M.   Perry Caroline M.  

Publisher： Adis International

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.4, Iss.4, 2005-01, pp. : 247-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib: In Advanced Pancreatic Cancer

By Simpson Dene   Scott Lesley J.   Noble Stuart  

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 35-40

Adis International

Access to resources Recommend Favorite

Treatment of multiple keratoacanthomas with erlotinib

By Reid David   Guitart Joan   Agulnik Mark   Lacouture Mario  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 413-415

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib in Glioblastoma - Lost in Translation?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 8, 2011-01 ,pp. : 748-755

Bentham Science Publishers

Access to resources Recommend Favorite

Erlotinib: A Targeted Anticancer Drug

By  

Current Cancer Therapy Reviews, Vol. 13, Iss. 1, 2017-08 ,pp. : 3-16

Bentham Science Publishers

Access to resources Recommend Favorite

Erlotinib: A Viewpoint by Natasha B. Leighl

By Leighl Natasha B.  

American Journal of Cancer, Vol. 4, Iss. 4, 2005-01 ,pp. : 253-254

Adis International

Access to resources Recommend Favorite